Agiliti Health Recalls Adapt Pump Support Surfaces Due to Software Malfunction

FDA Recalls medium FDA · · United States

Agiliti Health is recalling 4,286 Adapt Pumps used in medical support surfaces because a software bug prevents the Microclimate Management function from restarting after an Autofirm cycle.

What Happened

Agiliti Health - Ellis has initiated a voluntary Class II recall of its Adapt Pump (Model 61600200) used with several medical support surfaces. The company identified a software defect where the Microclimate Management function fails to re-engage after the “Autofirm” function’s 10-minute timer elapses. This issue occurs specifically when the timer is allowed to run out after the initial setup and affects only the Microclimate Management function.

Which Products Are Affected

The recall affects 4,286 units distributed nationwide across the United States. Affected products include:

  • Product Name: Adapt Pump (Component of Adapt support surfaces including Adapt Air, Adapt Air EX, Adapt Air Pro, Adapt Air Pro EX, Adapt Convertible, and Adapt Convertible EX)
  • Model/Catalog Number: 61600200
  • Software Version: 1.3.0
  • Identification: UDI-DI 0084569904914. This recall includes all serial numbers with a manufacturing date prior to December 4, 2025.

What You Should Do

Agiliti Health initiated the notification process via email on January 21, 2026. Facilities and healthcare providers using these support surfaces should be aware that the Microclimate Management function may not automatically resume after using the Autofirm setting. For more information regarding the status of the recall or technical support, contact Agiliti Health - Ellis at their 204 W 2nd St location in Ellis, Kansas.

Why This Matters

The failure of the Microclimate Management function to re-engage could compromise the therapeutic environment provided by the air flotation and alternating pressure mattresses, potentially impacting patient care.

Source

Information provided by the FDA under recall number Z-1472-2026.

Source: FDA Official Notice